More about

Alzheimer's Disease

News
August 01, 2024
2 min read
Save

Suvorexant acutely effective in reducing Alzheimer’s-related biomarkers

Suvorexant acutely effective in reducing Alzheimer’s-related biomarkers

PHILADELPHIA — In cognitively healthy but sleep-poor adults in midlife, treatment with 20 mg suvorexin led to acute decreases in Alzheimer’s-related biomarkers compared with 10 mg of the drug and placebo, according to a presenter.

News
July 31, 2024
3 min read
Save

Eliminating these 14 risk factors may prevent nearly half of dementia cases

Eliminating these 14 risk factors may prevent nearly half of dementia cases

PHILADELPHIA — Tackling 14 risk factors for dementia beginning in childhood could prevent or delay nearly half of cases, according to a report from the Lancet Commission presented at the Alzheimer's Association International Conference.

News
July 31, 2024
1 min read
Save

Processed red meat intake linked to 14% higher risk for dementia

Processed red meat intake linked to 14% higher risk for dementia

PHILADELPHIA — Individuals who consumed about two weekly servings of processed red meat had a 14% higher risk for dementia, as well as accelerated cognitive aging, vs. those who ate less than three servings a month, according to research.

News
July 30, 2024
2 min read
Save

Asthma associated with increased risk for Alzheimer’s disease

Asthma associated with increased risk for Alzheimer’s disease

The incidence and prevalence of Alzheimer’s disease was positively associated with an increased risk for asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

News
July 30, 2024
2 min read
Save

Liraglutide may slow cognitive decline, brain volume loss in patients with AD dementia

Liraglutide may slow cognitive decline, brain volume loss in patients with AD dementia

PHILADELPHIA — Treatment with liraglutide appeared to reduce cognitive decline and slow volume loss in several areas of the brain after 1 year among individuals with mild to moderate Alzheimer’s dementia, according to new research.

News
July 30, 2024
2 min read
Save

Blood test for AD pathology demonstrates higher predictive accuracy than clinicians

Blood test for AD pathology demonstrates higher predictive accuracy than clinicians

PHILADELPHIA — Utilization of a specialized blood test to detect Alzheimer’s-related pathology led to higher diagnostic accuracy compared to health care professionals’ identification, data show.

News
July 25, 2024
1 min read
Save

Annovis secures US patent for buntanetap

Annovis secures US patent for buntanetap

Annovis Bio Inc. has secured a U.S. patent for methods of treating acute traumatic brain injuries with its lead drug candidate, an oral, small molecule neurotoxic protein inhibitor.

News
July 23, 2024
1 min read
Save

Lantheus acquires Meilleur, including global rights to PET imaging agent for Alzheimer’s

Lantheus acquires Meilleur, including global rights to PET imaging agent for Alzheimer’s

Lantheus Holdings Inc. has announced the acquisition of Meilleur Technologies Inc., which includes the transfer of its rights to an amyloid-beta positron emission tomography imaging agent.

News
July 22, 2024
1 min read
Save

FDA grants fast-track designation to cellular therapy for mild Alzheimer’s

FDA grants fast-track designation to cellular therapy for mild Alzheimer’s

The FDA has granted fast-track designation to a proprietary, scalable, allogeneic, investigational cellular therapy in development to address symptoms of mild Alzheimer’s disease, according to the manufacturer.

News
July 17, 2024
1 min read
Save

NYU Langone tops list again as best US hospital for neurology, neurosurgery

NYU Langone tops list again as best US hospital for neurology, neurosurgery

NYU Langone was again the top hospital in the United States for neurology and neurosurgery, according to the latest annual Best Hospitals Survey issued by U.S. News & World Report.

View more